Three GLP-1 medications will be covered under the Medicare GLP-1 Bridge Program: Who Is Eligible
Over the course of a two-day meeting at FDAs headquarters in Silver Spring, MD that will continue Friday, the agencys Pharmacy Compounding Advisory Committee (PCAC) will consider a total of seven popular peptides to be eligible for pharmacy compounding
"Seeking Differentiation Through a Triple Mechanism" Eli Lillys Retatrutide Again Proves Efficacy in Trials, Raising Question of Whether It Can Overcome Side-Effect Limits and Reshape the Market Authored On Modified Eli Lilly consistently confirms therapeutic efficacy in clinical trials of retatrutide Triple-action GLP-1, GIP and glucagon mechanism maximizes weight-loss effect Side effects including gastrointestinal dysfunction remain clear, requiring further study and improvement in additional trials A shift is emerging in the obesity and diabetes drug market

Key monitoring recommendations include: Baseline testosterone assessment for men with symptoms of hypogonadism before starting semaglutide Evaluation of new or worsening symptoms during treatment with comprehensive metabolic and hormonal testing as clinically indicated Continued monitoring for patients on testosterone replacement therapy according to standard guidelines Consideration of nutritional status, sleep quality, and psychological factors when interpreting symptoms Referral to endocrinology for complex cases or when hormonal abnormalities are identified Patients should be counseled that significant weight loss itself typically improves testosterone levels in men with obesity and that any concerning symptoms should be reported promptly for appropriate evaluation
We need to have the best-in-class launches, especially as competition is increasing, Doustdar said in a call with reporters
These recipes are built around lean protein, fiber-rich vegetables, and simple ingredients that are easier to tolerate when your appetite is low